Stony Brook Telehealth Study
| Status: | Recruiting |
|---|---|
| Healthy: | No |
| Age Range: | 30 - Any |
| Updated: | 5/20/2018 |
| Start Date: | June 1, 2017 |
| End Date: | May 30, 2018 |
| Contact: | Kimberly Noel, MD MPH |
| Email: | kimberly.noel@stonybrookmedicine.edu |
| Phone: | 6314442032 |
Stony Brook Telehealth Study. Tele-transitions of Care. An Approach to Reduce 30-day Readmission Using Tele-Health Technology; A Randomized Controlled Trial
The study evaluates the feasibility of providing tele-transition of care, using risk
stratification, novel data tools, remote patient monitoring and virtual visits. A new
communication tool for relaying tele-communication among providers caring for the virtual
patient is introduced. The primary endpoint is 30-day readmissions.
stratification, novel data tools, remote patient monitoring and virtual visits. A new
communication tool for relaying tele-communication among providers caring for the virtual
patient is introduced. The primary endpoint is 30-day readmissions.
The objective is to evaluate the feasibility and effectiveness of a patient-centered,
physician led, transition of care, telehealth intervention. The intervention begins at the
bedside prior to hospital discharge and involves remote patient monitoring of daily vitals,
weekly virtual visits, detailed Electronic Medical Record (EMR) documentation and use of risk
stratification as well as data from the Health Information Exchange (HIE).
The hypothesis is that in comparison to standard care:
1. Preventable hospital readmissions will be reduced through patient-centered virtual
visits, daily biometric surveillance, and increased data access.
2. Patient satisfaction during the transition of care period will be improved
3. Adverse healthcare outcomes leading to ED visits or death will be reduced The primary
aim of the study is to determine the effect of telehealth on unplanned hospital
readmissions within 30 days of the index hospitalization discharge. In addition, data is
collected in order to provide secondary analyses on the effect of telehealth on
emergency department utilization, patient satisfaction, qualitative patient experience,
patient self-management and self-efficacy attitudes.
The Telehealth patient is provided with a smart phone device and Bluetooth-enabled blood
pressure monitoring cuff, weighing scale, and pulse oximeter. Telehealth patients measure
their vitals daily and have weekly virtual visits with a transition of care physician
(teledoc). The teledoc in this trial, is a senior resident physician in preventive medicine
or family medicine.
Patient enrollment and randomization occurs at the bedside prior to hospital discharge. All
patients are consented for the HIE in addition to the trial, and are risk stratified though
an EMR data, based validated algorithm. The care management team is notified of all study
participants in order to communicate to the telehealth team the date and time of hospital
discharge. An introduction is made in person with the teledoc to evaluate the patient in
person prior to virtual visits. Upon hospital discharge the patient receives the telehealth
equipment by a vendor service to their home within 48 hours.
Risk stratification is done by an internally and externally validated High Risk Readmission
Tool across many different hospital systems.
The patient follows prompts from the smart phone to register vitals daily, using a blood
pressure cuff, pulse oximeter and digital scale. The teledoc determines the safety range
parameters of the vitals depending on the patient clinical history and status. The telehealth
vendor, notifies the teledoc of any abnormal values.
Weekly telehealth visits are conducted for the first 30 days after a hospitalization.
physician led, transition of care, telehealth intervention. The intervention begins at the
bedside prior to hospital discharge and involves remote patient monitoring of daily vitals,
weekly virtual visits, detailed Electronic Medical Record (EMR) documentation and use of risk
stratification as well as data from the Health Information Exchange (HIE).
The hypothesis is that in comparison to standard care:
1. Preventable hospital readmissions will be reduced through patient-centered virtual
visits, daily biometric surveillance, and increased data access.
2. Patient satisfaction during the transition of care period will be improved
3. Adverse healthcare outcomes leading to ED visits or death will be reduced The primary
aim of the study is to determine the effect of telehealth on unplanned hospital
readmissions within 30 days of the index hospitalization discharge. In addition, data is
collected in order to provide secondary analyses on the effect of telehealth on
emergency department utilization, patient satisfaction, qualitative patient experience,
patient self-management and self-efficacy attitudes.
The Telehealth patient is provided with a smart phone device and Bluetooth-enabled blood
pressure monitoring cuff, weighing scale, and pulse oximeter. Telehealth patients measure
their vitals daily and have weekly virtual visits with a transition of care physician
(teledoc). The teledoc in this trial, is a senior resident physician in preventive medicine
or family medicine.
Patient enrollment and randomization occurs at the bedside prior to hospital discharge. All
patients are consented for the HIE in addition to the trial, and are risk stratified though
an EMR data, based validated algorithm. The care management team is notified of all study
participants in order to communicate to the telehealth team the date and time of hospital
discharge. An introduction is made in person with the teledoc to evaluate the patient in
person prior to virtual visits. Upon hospital discharge the patient receives the telehealth
equipment by a vendor service to their home within 48 hours.
Risk stratification is done by an internally and externally validated High Risk Readmission
Tool across many different hospital systems.
The patient follows prompts from the smart phone to register vitals daily, using a blood
pressure cuff, pulse oximeter and digital scale. The teledoc determines the safety range
parameters of the vitals depending on the patient clinical history and status. The telehealth
vendor, notifies the teledoc of any abnormal values.
Weekly telehealth visits are conducted for the first 30 days after a hospitalization.
Inclusion Criteria:
- Family Medicine Patients who are:
- Age 30 years or older
- Able to provide consent for their own care
- English speakers (able to comprehend and speak English)
- Patients with good cognitive function (as evidence by ability to answer a mild
cognitive screen (age, telephone, current date, name of facility)
- Living within reasonable commute to the Family Medical Group clinics
- Patients with a life expectancy greater than 6 months
- Patients with a clinical disposition to home after hospital discharge
- Patients that are able to turn on the telehealth technology and follow prompts
Exclusion Criteria:
- Uninsured patients who are not currently seen by the Family Medicine Practice
- Patients whose physical limitations prohibit the use of the telehealth equipment
- Patients involved in another research study
- Pregnant patients (patients actively trying to conceive)
- Admission for a psychiatric primary diagnosis
We found this trial at
1
site
Click here to add this to my saved trials
